Valuation dashboard for SANUWAVE Health Inc. (SNWV) with P/E 2.47, P/B 12.75, EV/EBITDA 2.42 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration.
Analysis Summary
SANUWAVE Health Inc. reported revenue of $44.1M in the most recent fiscal year, growing at a 5-year CAGR of 61.1%.
Trailing-twelve-month margins: gross margin 75.2%, operating margin 1.5%, net margin 32.6%.
At the current price of $4.43, SNWV trades at a P/E of 2.47 and an ROE of 17.28%. Market capitalisation stands at $38M.
Balance sheet quality for SNWV: current ratio of 1.4. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 2.47 |
| Price / Book | 12.75 |
| EV / EBITDA | 2.42 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $-26.60 |
| vs Current Price | -700.4% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| SNWV | SANUWAVE Health Inc. | $36M | 2.47 | 12.75 | 17.3% |
| ABT | Abbott Laboratories | $176.8B | 32.91 | 3.49 | 10.5% |
| 0Y6X.L | Medtronic Plc | $121.8B | |||
| MDT | Medtronic plc | $120.0B | 22.68 | 2.36 | 10.6% |
| SYK | Stryker Corporation | $109.2B | 28.79 | 4.48 | 16.4% |
| 0R2S.L | Stryker Corporation | $105.5B | 28.60 | 4.45 | 16.4% |
| BSX | Boston Scientific Corporation | $65.2B | 17.71 | 2.60 | 14.9% |
| 0HOY.L | Boston Scientific Corporation | $64.6B | 47.45 | 5.68 | 11.9% |
Price
| Price | $4.43 |
| Market Cap | $38M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 1728.10% |
| Return on Invested Capital | 2.80% |
| Return on Assets | 39.10% |
| Gross Margin | 75.20% |
| Operating Margin | 1.54% |
| Net Margin | 32.60% |
Related companies: FHTX · HSDT · IMRX · INGN · MASS · NNOX · OM
Explore sector: Healthcare · Medical - Devices
More sections of SNWV: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks